Product Information
DIAZEPAM 5 MG/ML ORAL CONC is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $1.0620 per ML under NDC 00054318544. Its NADAC has been published 593 times since Nov 28, 2013.
FDA first approved this application on Apr 3, 1987. Its Orange Book therapeutic-equivalence code is AA.
Strength
5 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054318544
Classification
Generic
Dosage Form
SOLUTION, CONCENTRATE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DIAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA071415FDA Approved
4/3/1987
TE Code
AA
On Market Since
4/3/1987
Pharmacological Classes
Price Statistics
The NADAC for DIAZEPAM 5 MG/ML ORAL CONC has been published 593 times since Nov 28, 2013, and over the history we have for it it has risen 27.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0620 per ML |
|---|---|
| All-time high | $1.0620 (Sep 30, 2026) |
| All-time low | $0.7313 (Aug 18, 2021) |
| 52-week high | $1.0620 |
| 52-week low | $0.9845 |
| Median price | $0.9271 |
| Average price | $0.9176 |
| Largest weekly change | +28.7% (Apr 17, 2024) |
| Weeks tracked | 593 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Diazepam Intensol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diazepam Intensol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIAZEPAM 5 MG/ML ORAL CONC?
The current National Average Drug Acquisition Cost (NADAC) for DIAZEPAM 5 MG/ML ORAL CONC, manufactured by Hikma Pharmaceuticals USA Inc., is $1.0620 per ML (NDC 00054318544), effective Sep 30, 2026.
How has the price of DIAZEPAM 5 MG/ML ORAL CONC changed over time?
Over the history we have for it, the NADAC for DIAZEPAM 5 MG/ML ORAL CONC has risen 27.4%. It has been tracked across 593 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DIAZEPAM 5 MG/ML ORAL CONC?
Since Nov 28, 2013, the NADAC for DIAZEPAM 5 MG/ML ORAL CONC has ranged from a low of $0.7313 (Aug 18, 2021) to a high of $1.0620 (Sep 30, 2026), with a median of $0.9271 per ML.
Are there cheaper alternatives to DIAZEPAM 5 MG/ML ORAL CONC?
No other NADAC-published product currently shares the active ingredient and strength of DIAZEPAM 5 MG/ML ORAL CONC in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DIAZEPAM 5 MG/ML ORAL CONC?
DIAZEPAM 5 MG/ML ORAL CONC (NDC 00054318544) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.